| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Prospective Study |
| Article Title |
Digestive and breast cancer patients managed during the first wave of COVID-19 pandemic: Short and middle term outcomes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jacobo Trébol, Ana Carabias-Orgaz, María Carmen Esteban-Velasco, Asunción García-Plaza, Juan Ignacio González‐Muñoz, Ana Belen Sánchez-Casado, Felipe Carlos Parreño-Manchado, Marta Eguía-Larrea and José Antonio Alcázar-Montero |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jacobo Trébol, MD, PhD, Reader (Associate Professor), Surgeon, Surgical Oncologist, Cirugía General y del Aparato Digestivo, Complejo Asistencial Universitario de Salamanca, Paseo de la Transición Española S/N , Salamanca 37007, Salamanca, Spain. jacobotrebol@gmail.com |
| Key Words |
COVID-19; SARS-CoV-2; Colon cancer; Rectal cancer; Breast cancer; Liver cancer; Pancreatic cancer; Gastric cancer; Oesophageal cancer; Surgery |
| Core Tip |
In our department, during coronavirus disease 2019 (COVID-19) first wave, all surgery was discontinued and resumed later for cancer patients. To minimise perioperative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, we established a physically separated clean pathway and adopted some practice modifications. We evaluated 96 malignancies; 88 underwent surgery (one SARS-CoV-2 positive): 49 colorectal, 20 breast, 12 liver-pancreatic and 7 oesophago-gastric. Three never received surgery because they contracted COVID-19. 78.2% were treated in alternative buildings, 43.8% waited more than 4 wk, two additional stomas were constructed, and laparoscopy decreased. None contracted perioperative SARS-CoV-2. Clean pathways are essential to continue cancer surgery during pandemics. Despite practice changes, we obtained comparable to standard outcomes. |
| Publish Date |
2024-06-14 09:10 |
| Citation |
<p>Trébol J, Carabias-Orgaz A, Esteban-Velasco MC, García-Plaza A, González‐Muñoz JI, Sánchez-Casado AB, Parreño-Manchado FC, Eguía-Larrea M, Alcázar-Montero JA. Digestive and breast cancer patients managed during the first wave of COVID-19 pandemic: Short and middle term outcomes. <i>World J Methodol</i> 2024; 14(2): 92612</p> |
| URL |
https://www.wjgnet.com/2222-0682/full/v14/i2/92612.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v14.i2.92612 |
